annual CFO:
-$395.89M+$18.44M(+4.45%)Summary
- As of today (June 30, 2025), CYTK annual cash flow from operations is -$395.89 million, with the most recent change of +$18.44 million (+4.45%) on December 31, 2024.
- During the last 3 years, CYTK annual CFO has fallen by -$253.37 million (-177.77%).
- CYTK annual CFO is now -1170.49% below its all-time high of $36.98 million, reached on December 31, 2016.
Performance
CYTK Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$131.62M-$66.05M(-100.73%)Summary
- As of today (June 30, 2025), CYTK quarterly cash flow from operations is -$131.62 million, with the most recent change of -$66.05 million (-100.73%) on March 1, 2025.
- Over the past year, CYTK quarterly CFO has dropped by -$2.11 million (-1.63%).
- CYTK quarterly CFO is now -269.11% below its all-time high of $77.83 million, reached on December 31, 2016.
Performance
CYTK quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$398.00M-$2.11M(-0.53%)Summary
- As of today (June 30, 2025), CYTK TTM cash flow from operations is -$398.00 million, with the most recent change of -$2.11 million (-0.53%) on March 1, 2025.
- Over the past year, CYTK TTM CFO has increased by +$23.55 million (+5.59%).
- CYTK TTM CFO is now -1176.20% below its all-time high of $36.98 million, reached on December 31, 2016.
Performance
CYTK TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
CYTK Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +4.5% | -1.6% | +5.6% |
| 3 y3 years | -177.8% | -390.9% | -184.7% |
| 5 y5 years | -335.5% | -336.8% | -322.8% |
CYTK Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -177.8% | +4.5% | -390.9% | at low | -184.7% | +9.2% |
| 5 y | 5-year | -4526.8% | +4.5% | -352.4% | at low | -4263.6% | +9.2% |
| alltime | all time | -1170.5% | +4.5% | -269.1% | at low | -1176.2% | +9.2% |
CYTK Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$131.62M(+100.7%) | -$398.00M(+0.5%) |
| Dec 2024 | -$395.89M(-4.5%) | -$65.57M(-35.4%) | -$395.89M(-2.1%) |
| Sep 2024 | - | -$101.50M(+2.2%) | -$404.36M(+1.3%) |
| Jun 2024 | - | -$99.31M(-23.3%) | -$399.06M(-5.3%) |
| Mar 2024 | - | -$129.51M(+74.9%) | -$421.55M(+1.7%) |
| Dec 2023 | -$414.33M(+38.3%) | -$74.04M(-23.0%) | -$414.33M(-5.5%) |
| Sep 2023 | - | -$96.20M(-21.0%) | -$438.49M(+2.9%) |
| Jun 2023 | - | -$121.81M(-0.4%) | -$426.32M(+7.9%) |
| Mar 2023 | - | -$122.29M(+24.5%) | -$394.99M(+31.9%) |
| Dec 2022 | -$299.52M(+110.2%) | -$98.19M(+16.8%) | -$299.52M(+21.7%) |
| Sep 2022 | - | -$84.04M(-7.1%) | -$246.06M(+22.5%) |
| Jun 2022 | - | -$90.47M(+237.5%) | -$200.79M(+43.6%) |
| Mar 2022 | - | -$26.81M(-40.1%) | -$139.81M(-1.9%) |
| Dec 2021 | -$142.52M(-1693.7%) | -$44.74M(+15.4%) | -$142.52M(+212.3%) |
| Sep 2021 | - | -$38.77M(+31.4%) | -$45.63M(-708.3%) |
| Jun 2021 | - | -$29.50M(-0.1%) | $7.50M(-21.5%) |
| Mar 2021 | - | -$29.52M(-156.6%) | $9.56M(+6.9%) |
| Dec 2020 | $8.94M(-109.8%) | $52.15M(+263.0%) | $8.94M(-114.4%) |
| Sep 2020 | - | $14.37M(-152.4%) | -$62.26M(-35.7%) |
| Jun 2020 | - | -$27.44M(-8.9%) | -$96.90M(+2.9%) |
| Mar 2020 | - | -$30.14M(+58.1%) | -$94.14M(+3.6%) |
| Dec 2019 | -$90.91M(-10.2%) | -$19.05M(-6.0%) | -$90.91M(+8.0%) |
| Sep 2019 | - | -$20.27M(-17.9%) | -$84.18M(-12.4%) |
| Jun 2019 | - | -$24.68M(-8.3%) | -$96.15M(-2.2%) |
| Mar 2019 | - | -$26.91M(+118.3%) | -$98.31M(-2.9%) |
| Dec 2018 | -$101.22M(-0.5%) | -$12.33M(-61.8%) | -$101.22M(-10.4%) |
| Sep 2018 | - | -$32.23M(+20.1%) | -$112.96M(+6.4%) |
| Jun 2018 | - | -$26.85M(-9.9%) | -$106.21M(-4.0%) |
| Mar 2018 | - | -$29.81M(+23.8%) | -$110.62M(+8.7%) |
| Dec 2017 | -$101.76M(-375.2%) | -$24.07M(-5.5%) | -$101.76M(<-9900.0%) |
| Sep 2017 | - | -$25.48M(-18.5%) | $141.00K(-99.0%) |
| Jun 2017 | - | -$31.26M(+49.3%) | $13.50M(-59.7%) |
| Mar 2017 | - | -$20.94M(-126.9%) | $33.55M(-9.3%) |
| Dec 2016 | $36.98M(+657.4%) | $77.83M(-742.0%) | $36.98M(-172.8%) |
| Sep 2016 | - | -$12.12M(+8.1%) | -$50.79M(+3.6%) |
| Jun 2016 | - | -$11.22M(-35.9%) | -$49.01M(+4.3%) |
| Mar 2016 | - | -$17.51M(+76.1%) | -$46.98M(-1062.2%) |
| Dec 2015 | $4.88M(-110.9%) | -$9.94M(-3.9%) | $4.88M(-27.1%) |
| Sep 2015 | - | -$10.35M(+12.6%) | $6.70M(-11.1%) |
| Jun 2015 | - | -$9.19M(-126.7%) | $7.53M(+2.6%) |
| Mar 2015 | - | $34.36M(-522.6%) | $7.34M(-116.4%) |
| Dec 2014 | -$44.84M | -$8.13M(-14.6%) | -$44.84M(-8.7%) |
| Sep 2014 | - | -$9.52M(+1.5%) | -$49.14M(+67.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2014 | - | -$9.38M(-47.4%) | -$29.32M(+120.1%) |
| Mar 2014 | - | -$17.82M(+43.4%) | -$13.32M(+72.6%) |
| Dec 2013 | -$7.72M(-76.9%) | -$12.43M(-220.6%) | -$7.72M(+219.9%) |
| Sep 2013 | - | $10.31M(+55.6%) | -$2.41M(-88.8%) |
| Jun 2013 | - | $6.62M(-154.2%) | -$21.60M(-41.5%) |
| Mar 2013 | - | -$12.22M(+71.6%) | -$36.92M(+10.4%) |
| Dec 2012 | -$33.44M(-26.7%) | -$7.12M(-19.8%) | -$33.44M(-10.3%) |
| Sep 2012 | - | -$8.88M(+2.1%) | -$37.26M(-1.0%) |
| Jun 2012 | - | -$8.70M(-0.4%) | -$37.65M(-9.2%) |
| Mar 2012 | - | -$8.74M(-20.2%) | -$41.45M(-9.1%) |
| Dec 2011 | -$45.59M(+1.7%) | -$10.95M(+18.1%) | -$45.59M(+4.2%) |
| Sep 2011 | - | -$9.26M(-25.9%) | -$43.74M(-2.4%) |
| Jun 2011 | - | -$12.51M(-2.9%) | -$44.79M(-1.6%) |
| Mar 2011 | - | -$12.88M(+41.7%) | -$45.50M(+1.5%) |
| Dec 2010 | -$44.83M(-632.7%) | -$9.09M(-11.9%) | -$44.83M(+6.5%) |
| Sep 2010 | - | -$10.32M(-21.9%) | -$42.09M(-2.9%) |
| Jun 2010 | - | -$13.21M(+8.2%) | -$43.34M(-642.0%) |
| Mar 2010 | - | -$12.21M(+92.4%) | $8.00M(-5.0%) |
| Dec 2009 | $8.42M(-113.7%) | -$6.35M(-45.1%) | $8.42M(+398.0%) |
| Sep 2009 | - | -$11.57M(-130.3%) | $1.69M(-150.9%) |
| Jun 2009 | - | $38.12M(-423.4%) | -$3.32M(-94.4%) |
| Mar 2009 | - | -$11.79M(-9.8%) | -$59.29M(-3.3%) |
| Dec 2008 | -$61.33M(+1940.9%) | -$13.07M(-21.1%) | -$61.33M(-1.6%) |
| Sep 2008 | - | -$16.58M(-7.2%) | -$62.29M(+11.3%) |
| Jun 2008 | - | -$17.86M(+29.2%) | -$55.96M(+8.5%) |
| Mar 2008 | - | -$13.82M(-1.5%) | -$51.56M(+1615.7%) |
| Dec 2007 | -$3.00M(-93.6%) | -$14.04M(+37.0%) | -$3.00M(+40.5%) |
| Sep 2007 | - | -$10.25M(-23.8%) | -$2.14M(-39.8%) |
| Jun 2007 | - | -$13.45M(-138.7%) | -$3.55M(+144.8%) |
| Mar 2007 | - | $34.73M(-363.7%) | -$1.45M(-96.9%) |
| Dec 2006 | -$47.17M(+19.5%) | -$13.17M(+12.9%) | -$47.17M(+7.0%) |
| Sep 2006 | - | -$11.66M(+2.8%) | -$44.09M(+7.1%) |
| Jun 2006 | - | -$11.35M(+3.3%) | -$41.17M(-1.7%) |
| Mar 2006 | - | -$10.99M(+8.9%) | -$41.87M(+6.0%) |
| Dec 2005 | -$39.48M(+16.0%) | -$10.09M(+15.4%) | -$39.48M(-3.6%) |
| Sep 2005 | - | -$8.75M(-27.4%) | -$40.97M(-0.1%) |
| Jun 2005 | - | -$12.04M(+40.0%) | -$41.01M(+15.2%) |
| Mar 2005 | - | -$8.60M(-25.7%) | -$35.61M(+4.6%) |
| Dec 2004 | -$34.03M(+10.9%) | -$11.58M(+31.8%) | -$34.03M(+51.6%) |
| Sep 2004 | - | -$8.79M(+32.2%) | -$22.45M(+64.3%) |
| Jun 2004 | - | -$6.65M(-5.3%) | -$13.67M(+94.7%) |
| Mar 2004 | - | -$7.02M | -$7.02M |
| Dec 2003 | -$30.70M(+37.6%) | - | - |
| Dec 2002 | -$22.30M | - | - |
FAQ
- What is Cytokinetics Incorporated annual cash flow from operations?
- What is the all time high annual CFO for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated annual CFO year-on-year change?
- What is Cytokinetics Incorporated quarterly cash flow from operations?
- What is the all time high quarterly CFO for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated quarterly CFO year-on-year change?
- What is Cytokinetics Incorporated TTM cash flow from operations?
- What is the all time high TTM CFO for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated TTM CFO year-on-year change?
What is Cytokinetics Incorporated annual cash flow from operations?
The current annual CFO of CYTK is -$395.89M
What is the all time high annual CFO for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high annual cash flow from operations is $36.98M
What is Cytokinetics Incorporated annual CFO year-on-year change?
Over the past year, CYTK annual cash flow from operations has changed by +$18.44M (+4.45%)
What is Cytokinetics Incorporated quarterly cash flow from operations?
The current quarterly CFO of CYTK is -$131.62M
What is the all time high quarterly CFO for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high quarterly cash flow from operations is $77.83M
What is Cytokinetics Incorporated quarterly CFO year-on-year change?
Over the past year, CYTK quarterly cash flow from operations has changed by -$2.11M (-1.63%)
What is Cytokinetics Incorporated TTM cash flow from operations?
The current TTM CFO of CYTK is -$398.00M
What is the all time high TTM CFO for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high TTM cash flow from operations is $36.98M
What is Cytokinetics Incorporated TTM CFO year-on-year change?
Over the past year, CYTK TTM cash flow from operations has changed by +$23.55M (+5.59%)